UPDATE: On December 15, 2017, the FDA released an updated drug label for Gilenya with increased warnings. (12/27/17). Background After conducting a routine review of the immunosuppressive drug Gilenya (fingolimod), the Medicines and Healthcare Products Regulatory Agency (MHRA) recently suggested that the drug label for Gilenya be … [Read more...]
CNN Investigates Over-Prescription of Nuedexta in Nursing Homes
Late last week, CNN reported on the possible inappropriate prescribing of the drug Nuedexta in nursing homes in their article, "The little red pill being pushed on the elderly." Nuedexta is indicated for the treatment of pseudobulbar affect (PBA), a disorder estimated to affect less than 1% of all Americans. DailyMed provides the following … [Read more...]